SCHEMBL3786779

SCHEMBL3786779

Nc1ccc(-c2ccccc2)cc1OCc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.53
L3MBTL1 Q9Y468 3/20 0.53
MAPK1 P28482 2/20 0.53
ALDH1A1 P00352 2/20 0.53
HSD17B10 Q99714 2/20 0.53
KDM4E B2RXH2 1/20 0.53
MEN1 O00255 1/20 0.53
POLB P06746 1/20 0.53
HPGD P15428 1/20 0.53
KMT2A Q03164 1/20 0.53
MAP4K4 O95819 1/20 0.51
ALOX5AP P20292 1/20 0.48
APP P05067 1/20 0.47
LTA4H P09960 1/20 0.47
MAPK14 Q16539 1/20 0.47
AGXT P21549 3/20 0.47
IDO1 P14902 2/20 0.47
GAA P10253 2/20 0.47
MGAM O43451 1/20 0.47
SI P14410 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3788705 0.93 MAPT (0.54) MAPTL3MBTL1MAPK1ALDH1A1HSD17B10
SCHEMBL3786391 0.91 MAOB (0.55) MAPTL3MBTL1MAPK1ALDH1A1HSD17B10
SCHEMBL7489944 0.88 DHFR (0.49) MAPTL3MBTL1MAPK1ALDH1A1HSD17B10
SCHEMBL3793244 0.86 MRGPRX4 (0.48) MAPTL3MBTL1MAPK1ALDH1A1HSD17B10
SCHEMBL14259206 0.85 CYP11B1 (0.63) MAPK1ALDH1A1HSD17B10MEN1POLB
SCHEMBL3781528 0.85 APP (0.47) MAPTL3MBTL1MAPK1ALDH1A1HSD17B10
SCHEMBL3722814 0.82 ROCK2 (0.60) MAPTL3MBTL1MAPK1ALDH1A1HSD17B10
SCHEMBL22360072 0.82 DHFR (0.52) MAPTL3MBTL1MAPK1ALDH1A1HSD17B10
SCHEMBL8298067 0.82 MAOB (0.56) MAPTL3MBTL1MAPK1APPLTA4H
SCHEMBL8059557 0.81 LMNA (0.52) MAPTL3MBTL1MAPK1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 MAPT 3312/4885L3MBTL1 3838/4885MAPK1 4726/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.